Entero Therapeutics, Inc.

ENTONASDAQHealthcare

$2.85

$-0.15(-5.00%)

Market Cap$13582331

P/E Ratio—

52W High$5.84

52W Low$0.969

Avg Volume216K

Open$3.00

Beta1.19

Overview

Entero Therapeutics, Inc. (ENTO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ENTO · as of May 1, 2026

Latest filing snapshot

+2+100.00%vs prior year

Entero Therapeutics, Inc. (ENTO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+100.00%

Revenue / Employee

$9.1K

Net Income / Employee

$-1.64M

Market Cap

$14M

ENTO Employee Count

2016 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-05-01	2025-12-31	4	+2	+100.00%
2025-04-01	2024-12-31	2	-7	-77.78%
2024-03-29	2023-12-31	9	-1	-10.00%
2023-03-20	2022-12-31	10	-7	-41.18%
2022-03-31	2021-12-31	17	+5	+41.67%
2021-03-31	2020-12-31	12	+2	+20.00%
2020-03-30	2019-12-31	10	-2	-16.67%
2019-04-01	2018-12-31	12	-1	-7.69%
2018-03-16	2017-12-31	13	+2	+18.18%
2017-03-31	2016-12-31	11	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

BriaCell Therapeutics Corp.

Allarity Therapeutics, Inc.

6$25M #6

ENTO

Entero Therapeutics, Inc.YOU

4$14M #7

ASBP

Aspire Biopharma Holdings, Inc.

2$1M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ENTO peer comparison

About ENTO employees

ENTO Employees · Headcount

Entero Therapeutics, Inc. (ENTO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Entero Therapeutics, Inc. had 4 full-time employees globally. Full-time employees only. Global consolidated headcount.

Entero Therapeutics, Inc. employs 4 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $9,063, reflecting the company's operational efficiency.

Entero Therapeutics, Inc.'s workforce increased by 2 (100.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Entero Therapeutics, Inc.'s revenue per employee of $9,063 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ENTO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Entero Therapeutics, Inc. had 4 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Entero Therapeutics, Inc. employee counthow many employees does Entero Therapeutics, Inc. haveENTO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-05-01